PMID: 22563663May 9, 2012Paper

Stem cells from umbilical cord and placenta for musculoskeletal tissue engineering

Current Stem Cell Research & Therapy
Umile Giuseppe LongoVincenzo Denaro

Abstract

Mesenchymal stem cells isolated from amnion/amniotic fluid, umbilical cord blood, placental tissue, umbilical cord vein and the Wharton's Jelly are promising candidates for musculoskeletal tissue engineering of bone and cartilage tissues. The extracorporeal nature of this source avoids the ethical concerns that plague the isolation of embryonic stem cells. Moreover, the harvesting does not require the invasive and discomfort extraction procedures as well as patient risks that attend adult stem cell isolation. Current preclinical studies support the application of these cell-based therapies for the regeneration of musculoskeletal tissues. We performed a review of the literature to focus on actual knowledge and the future perspectives of the stem cells deriving from umbilical cord and placenta for musculoskeletal tissue engineering.

Citations

Jan 28, 2014·Differentiation; Research in Biological Diversity·Hsi-Yi YehShan-Hui Hsu
Nov 5, 2013·Mayo Clinic Proceedings·Christopher H Evans
Dec 7, 2013·BioMed Research International·Marta BarbaWanda Lattanzi
Oct 31, 2015·PloS One·Gabriele BonaventuraMaria Luisa Barcellona
Apr 5, 2017·Expert Opinion on Biological Therapy·Marta BarbaWanda Lattanzi
Feb 14, 2018·Expert Opinion on Biological Therapy·Jakub SmolarDaniel Eberli
Oct 10, 2018·Regenerative Medicine·Nadia NaseerSheikh Riazuddin
Jul 6, 2019·The Journal of Bone and Joint Surgery. American Volume·Richard MaScott A Rodeo
Oct 9, 2014·Experimental Biology and Medicine·Jung-Sun ChoHeung-Man Lee
Feb 2, 2018·Biotechnology & Genetic Engineering Reviews·Behnaz BakhshandehZarrintaj Ziraksaz
Feb 28, 2013·ACS Nano·Habib NikukarMatthew J Dalby

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.